114 related articles for article (PubMed ID: 12819803)
1. The impact of new technologies on drug design.
Norman P
Drug News Perspect; 2001 Mar; 14(2):123-8. PubMed ID: 12819803
[TBL] [Abstract][Full Text] [Related]
2. The Role of Bioinformatics in Identifying and Defining Potential Drug Targets.
Norman P
Drug News Perspect; 2002 May; 15(4):253-256. PubMed ID: 12677210
[TBL] [Abstract][Full Text] [Related]
3. New drug targets in inflammation and immunomodulation.
Norman P
Drug News Perspect; 1998 Sep; 11(7):442-7. PubMed ID: 15616686
[TBL] [Abstract][Full Text] [Related]
4. Medicinal Chemistry--XVth EFMC International Symposium. New technologies in drug discovery. 6-10 September 1998, Edinburgh, Scotland, UK.
Buckle DR
IDrugs; 1998 Dec; 1(8):860-2. PubMed ID: 16196472
[TBL] [Abstract][Full Text] [Related]
5. Natural Products as a Source of New Drugs.
Norman P
Drug News Perspect; 2002 Sep; 15(7):461-465. PubMed ID: 12677183
[TBL] [Abstract][Full Text] [Related]
6. From virtuality to reality - Virtual screening in lead discovery and lead optimization: a medicinal chemistry perspective.
Rester U
Curr Opin Drug Discov Devel; 2008 Jul; 11(4):559-68. PubMed ID: 18600572
[TBL] [Abstract][Full Text] [Related]
7. Importance of molecular computer modeling in anticancer drug development.
Geromichalos GD
J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
[TBL] [Abstract][Full Text] [Related]
8. The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones.
Workman P
Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S45-56. PubMed ID: 12819933
[TBL] [Abstract][Full Text] [Related]
9. Structure-based design of molecular cancer therapeutics.
van Montfort RL; Workman P
Trends Biotechnol; 2009 May; 27(5):315-28. PubMed ID: 19339067
[TBL] [Abstract][Full Text] [Related]
10. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
Marrero-Ponce Y; Iyarreta-VeitÃa M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
[TBL] [Abstract][Full Text] [Related]
11. Virtual screening in lead discovery and optimization.
Jain AN
Curr Opin Drug Discov Devel; 2004 Jul; 7(4):396-403. PubMed ID: 15338948
[TBL] [Abstract][Full Text] [Related]
12. The 7 TM G-protein-coupled receptor target family.
Jacoby E; Bouhelal R; Gerspacher M; Seuwen K
ChemMedChem; 2006 Aug; 1(8):761-82. PubMed ID: 16902930
[TBL] [Abstract][Full Text] [Related]
13. Novel technologies for virtual screening.
Lengauer T; Lemmen C; Rarey M; Zimmermann M
Drug Discov Today; 2004 Jan; 9(1):27-34. PubMed ID: 14761803
[TBL] [Abstract][Full Text] [Related]
14. Medicinal Chemistry in eastern England--tenth symposium. 22 April 1999, University of Hertfordshire, Hatfield, UK.
Norman P
IDrugs; 1999 Jul; 2(7):659-63. PubMed ID: 16127635
[TBL] [Abstract][Full Text] [Related]
15. Structure-based drug design of new leads for phosphatase research.
Combs AP
IDrugs; 2007 Feb; 10(2):112-5. PubMed ID: 17285463
[TBL] [Abstract][Full Text] [Related]
16. Application and limitations of X-ray crystallographic data in structure-based ligand and drug design.
Davis AM; Teague SJ; Kleywegt GJ
Angew Chem Int Ed Engl; 2003 Jun; 42(24):2718-36. PubMed ID: 12820253
[TBL] [Abstract][Full Text] [Related]
17. Protease Inhibition: Design, Technology & Opportunities--First RSC/SCI Symposium on Protease Inhibition.18-19 May 1998, London, UK.
Buckle DR
IDrugs; 1998 Jun; 1(2):185-8. PubMed ID: 18465527
[TBL] [Abstract][Full Text] [Related]
18. Virtual screening strategies in drug discovery.
McInnes C
Curr Opin Chem Biol; 2007 Oct; 11(5):494-502. PubMed ID: 17936059
[TBL] [Abstract][Full Text] [Related]
19. Integrated in silico tools for exploiting the natural products' bioactivity.
Rollinger JM; Langer T; Stuppner H
Planta Med; 2006 Jun; 72(8):671-8. PubMed ID: 16783689
[TBL] [Abstract][Full Text] [Related]
20. A watershed of new knowledge in biomedical sciences.
Boyd B
Drug News Perspect; 2001 May; 14(4):248-56. PubMed ID: 12819796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]